Dextroamphetamine

Back to search

Molecule Structure

Scientific Name

Dextroamphetamine

Description of the Drug

Dextroamphetamine is a sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01576

Brand Name(s)

Dexedrine, Dextrostat, Xelstrym

Company Owner(s)

Vitarine Pharmaceuticals Inc, Glaxosmithkline, Takeda Pharmaceuticals Usa Inc, Sun Pharmaceutical Industries Inc, Nesher Pharmaceuticals Usa Llc, Halsey Drug Co Inc, Elite Laboratories Inc, Outlook Pharmaceuticals Inc, Rhodes Pharmaceuticals Lp, Shire Development Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Synaptic vesicular amine transporter SINGLE PROTEIN INHIBITOR CHEMBL1893
Dopamine transporter SINGLE PROTEIN RELEASING AGENT CHEMBL238
Norepinephrine transporter SINGLE PROTEIN RELEASING AGENT CHEMBL222

Unichem Links

SureChEMBL SCHEMBL8859
PharmGKB PA449269 PA448408
Human Metabolome Database HMDB0015516
DrugBank DB01576
PubChem: Thomson Pharma 15170721
PubChem 5826
NMRShiftDB 60021631
Nikkaji J4.121A
PDBe 1WE
BindingDB 50022723
EPA CompTox Dashboard DTXSID8022907
DrugCentral 841
Brenda 3808 40962 42060
Guide to Pharmacology 2147
rxnorm DEXTROAMPHETAMINE SULFATE DEXTROAMPHETAMINE DEXTROAMPHETAMINE SACCHARATE DEXEDRINE
KEGG Ligand C07884
ChEBI 4469
ZINC ZINC000006021033